9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 60 filers reported holding 9 METERS BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -16.7% | 22,332 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -53.8% | 22,332 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -40.9% | 22,332 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | -24.1% | 22,332 | 0.0% | 0.00% | – |
| Q3 2021 | $29,000 | +16.0% | 22,332 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -100.0% | 22,332 | -50.0% | 0.00% | – |
| Q1 2021 | $52,256,000 | +180093.1% | 44,664 | +30.1% | 0.00% | -100.0% |
| Q4 2020 | $29,000 | +3.6% | 34,332 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | +1300.0% | 34,332 | +775.4% | 0.00% | – |
| Q2 2020 | $2,000 | – | 3,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
| ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
| Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
| Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
| Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
| Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
| Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
| Almanack Investment Partners, LLC. | 40,850 | $53,000 | 0.01% |